ABVX vs AGIO Stock Comparison

AGIO currently leads ABVX in this stock comparison, with AIQ scores of 56 vs 35. The clearest difference is momentum.

Market data as of Nov 15, 2026 market close· AIQ score gap 21 points
ABVX
Healthcare
vs
AGIO
Healthcare
ABVX
Abivax S.A.
Price
$87.58
Day move
-2.9%
AIQ Score
35/100
Best edge
Balanced
Sector
Healthcare
AGIO
Agios Pharmaceuticals, Inc.
Leads
Price
$31.59
Day move
-0.54%
AIQ Score
56/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between ABVX and AGIO?

AGIO leads the current stock comparison as Agios Pharmaceuticals, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Abivax S.A. vs Agios Pharmaceuticals, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 8/10

AGIO leads

AGIO leads by 21 AIQ points, primarily on Momentum and Quality, and the lead has widened from 16 points over 30 sessions. Wall Street currently favors ABVX on target upside.

Competitive: 3 of 5 evidence groups support AGIO, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 3 of 5Comparison trend: Strengthening
ABVX

Abivax S.A.

AIQ Score
35/100
AIQ Edge Score
5/10
AGIO

Agios Pharmaceuticals, Inc.

Leads
AIQ Score
56/100
AIQ Edge Score
5/10

The Algovestiq AIQ Score currently favors AGIO over ABVX, 56 versus 35 as of Nov 15, 2026. AGIO's advantage is driven primarily by stronger momentum and quality. AGIO also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ABVX. 3 of 5 covered evidence groups favor AGIO today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. AGIO lead: Strengthening — the AIQ differential moved from 16 to 21 points over 30 sessions.

Compare Abivax S.A. and Agios Pharmaceuticals, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

ABVX
+955.2%
AGIO
+47.8%

Price return comparison

Growth of $10,000, price only

ABVX $105,518 · AGIO $14,775

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare ABVX and AGIO against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ABVX advantage
0
AGIO advantage
  • Momentum34 vs 61
    AGIO +27
  • Quality35 vs 58
    AGIO +23
  • Risk Resilience37 vs 47
    AGIO +10

3 of 5 evidence groups favor AGIO. AGIO’s edge is concentrated in momentum and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ABVX0 AIQ

Largest factor move: Risk Resilience +4, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 4 active signals are unchanged.

AGIO0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.30x)

AGIO's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — ABVX and AGIO both carry a full feed there.

The central trade-off

AGIO (Agios Pharmaceuticals, Inc.): the stronger current systematic profile, led by momentum and quality.

ABVX (Abivax S.A.): the counter-case, on analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

AGIO

AGIO on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AGIO

AGIO on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

AGIO

AGIO on the Momentum factor, by 27 points.

Lower downside

AGIO

AGIO on Risk Resilience, by 10 points.

Analyst upside

ABVX

ABVX on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors AGIO, analyst targets favor ABVX. That disagreement is the most useful thing on this page.

MeasureABVXAGIONote
Implied upside to target+61.4%+10.8%ABVX has more room
Target dispersion+26.2%0%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1210Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor AGIO. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreAGIO35 vs 56
FundamentalsEvenEPS growth 30% vs 35.5%; TTM ROE -32.1% vs -6.6%; gross margin 153.1% vs 91.9%; operating margin 119.5% vs -297.7%
ValuationNot coveredNot covered
TechnicalsAGIOPrice vs 50-day -7.7% vs -4.5%; vs 200-day -22.2% vs -0.8%
Risk ResilienceAGIORisk Resilience 37 vs 47
Analyst expectationsABVXTarget upside 61.4% vs 10.8%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ABVX and AGIO and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 21 points. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AGIO.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

AGIO lead: Strengthening — the AIQ differential moved from 16 to 21 points over 30 sessions.

May 27ABVX leads above the line · AGIO leads belowNov 13
Today
AGIO +21
35 vs 56
7 sessions ago
AGIO +24
33 vs 57
30 sessions ago
AGIO +16
33 vs 49
90 sessions ago
AGIO +10
48 vs 58

The lead changed hands once in this window, most recently on Jun 2 when AGIO moved ahead of ABVX.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ABVX

0 bullish / 2 bearish / 2 neutral

Only ABVX

  • Death Cross Active — bearish, trend, long horizon (18.68%)
  • Downtrend Structure Active — bearish, trend, long horizon
AGIOConflicted

1 bullish / 2 bearish / 2 neutral, conflicted

Only AGIO

  • Golden Cross Active — bullish, trend, long horizon (3.90%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.30x)

Both carry 2 more signals that do not separate them: ADX Trend Weakening, ATR Expansion - Breakout Mode.

AGIO leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ABVXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.9%, AIQ 0 points).

AGIONo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.54%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1ABVX closes the Momentum gap — currently 27 points behind, the largest single contributor to AGIO's edge.
  2. 2ABVX's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3AGIO's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricABVXAGIO
Revenue growth (YoY)0%23.8%
EPS growth (YoY)30%35.5%
Gross margin153.1%91.9%
Operating margin119.5%-297.7%
Return on equity (TTM)-32.1%-6.6%
Debt to equity00.03

Performance

AGIO leads 5 of 6 windows
MetricABVXAGIO
1 week (5 sessions)2.2%7.4%
1 month (20 sessions)-0.6%0.9%
3 months (63 sessions)-27.5%-6.1%
6 months (126 sessions)-23.5%12.1%
Year to date-35.1%16.1%
1 year (252 sessions)-15.3%-27.6%

Technicals

AGIO has the stronger structure
MetricABVXAGIO
RSI (14)45.546.3
ADX (14)19.420.6
Price vs 50-day-7.7%-4.5%
Price vs 200-day-22.2%-0.8%
Volatility (1M, annualized)47%96.3%

Risk

AGIO is the more resilient
MetricABVXAGIO
Beta1.180.93
Sharpe ratio0.240.07
Sortino ratio0.370.08
Max drawdown-50.1%-50.9%
Current drawdown-39.7%-30.6%
Annualized volatility86.4%80%
Value at risk (95%)-5.2%-3.9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ABVX or AGIO?

On the Algovestiq AIQ Score, AGIO is the stronger of the two as of Nov 15, 2026, scoring 56 against ABVX's 35. The edge comes from momentum and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ABVX or AGIO the better buy right now?

AGIO carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor AGIO over ABVX?

The composite weights Quality, Value, Momentum and Risk Resilience. AGIO leads Momentum by 27 points; AGIO leads Quality by 23 points; AGIO leads Risk Resilience by 10 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ABVX or AGIO?

Analyst price targets imply +61.4% upside for ABVX and +10.8% for AGIO, so the Street currently favors ABVX. That points the opposite way to the AIQ Score, which favors AGIO. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ABVX or AGIO?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ABVX or AGIO?

AGIO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ABVX or AGIO?

AGIO on the Momentum factor, by 27 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ABVX or AGIO?

AGIO is the more resilient of the two, so the other name carries the higher downside risk. AGIO on Risk Resilience, by 10 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ABVX more profitable than AGIO?

The profitability evidence is mixed: gross margin 153.1% vs 91.9%; operating margin 119.5% vs -297.7%; ttm roe -32.1% vs -6.6%. ABVX leads on two measures and AGIO on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is AGIO's lead over ABVX getting stronger or weaker?

AGIO lead: Strengthening — the AIQ differential moved from 16 to 21 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-06-02, when AGIO moved ahead of ABVX.

What would change the ABVX vs AGIO verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ABVX closes the Momentum gap — currently 27 points behind, the largest single contributor to AGIO's edge; ABVX's Death Cross Active resolves — a bearish trend rule currently active against it; AGIO's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ABVX and AGIO?

ABVX: 0 bullish / 2 bearish / 2 neutral. AGIO: 1 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ABVX is Death Cross Active (bearish, long horizon). On AGIO it is Golden Cross Active (bullish, long horizon).

Compare ABVX and AGIO with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.